Rajkumar Bafna, the President-Finance at Akums Drugs & Pharmaceuticals, has resigned from his position, citing concerns about Delhi's pollution levels and their impact on his health, according to company filings and regulatory disclosures.

Bafna's resignation, confirmed through official documentation, highlights the growing concerns surrounding air quality in Delhi, a persistent issue impacting residents and businesses alike. While the specific details of his health concerns remain private, his decision to resign points to the severity of the situation.

Akums Drugs & Pharmaceuticals is a significant contract manufacturer in the Indian pharmaceutical industry, producing a wide range of formulations for various companies. The departure of a senior executive like Bafna could potentially impact the company’s financial operations, although the extent of that impact remains to be seen. Company officials have not yet released a statement addressing Bafna’s resignation beyond the regulatory filings confirming his exit.

Delhi's air pollution has been a recurring problem, particularly during the winter months, often exceeding safe limits set by the World Health Organization. The pollution is a complex issue stemming from various sources, including vehicle emissions, industrial activity, construction dust, and seasonal crop burning in neighboring states. The city government has implemented several measures to combat pollution, but challenges persist.

The resignation underscores the personal toll that Delhi’s environmental challenges can take, even on high-ranking executives. Further updates will be provided as they become available regarding the transition in Akums Drugs' finance department and any official response from the company.